Экспертные центры тромбоэмболии легочных артерий: современные протоколы и инновационные методы лечения

Острая тромбоэмболия легочных артерий (ТЭЛА) – жизнеугрожающая патология, потенциально требующая применения широкого спектра диагностических, терапевтических и хирургических вмешательств. В связи со сложностью дифференциальной диагностики, принятия клинических решений, а также с активной разработкой современных методов лечения и диагностики ТЭЛА за рубежом развернута сеть профильных ТЭЛА-центров экспертного уровня. Подобные учреждения позволяют сконцентрировать квалифицированные врачебные кадры и высокотехнологичное оборудование для повышения качества медицинской помощи больным ТЭЛА промежуточно-высокого и высокого риска, а также для организации научно-образовательной базы для проведения будущих исследований и обновления клинических рекомендаций. Внедрение ТЭЛА-центров может позволить снизить госпитальную летальность, длительность пребывания пациентов в стационаре и отделении интенсивной терапии.

1. Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Experimental and Clinical Cardiology. 2013;18(2):129–38. PMID: 23940438

2. Никулина Н.Н., Тереховская Ю.В. Эпидемиология тромбоэмболии легочной артерии в современном мире: анализ заболеваемости, смертности и проблем их изучения. Российский кардиологический журнал. 2019;24(6):103-8. DOI: 10.15829/15604071-2019-6-103-108

3. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G-J, Harjola V-P et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2019;41(4):543–603. DOI: 10.1093/eurheartj/ehz405

4. Панченко Е.П., Балахонова Т.В., Данилов Н.М., Комаров А.Л., Кропачева Е.С., Саидова М.А. и др. Диагностика и лечение тромбоэмболии легочной артерии: клинические рекомендации Евразийской ассоциации кардиологов для практических врачей (2021). Евразийский Кардиологический Журнал. 2021;1(34):44–77. DOI: 10.38109/2225-1685-2021-1-44-77

5. Бокерия Л.А., Затевахин И.И., Кириенко А.И., Андрияшкин А.В., Андрияшкин В.В., Арутюнов Г.П. и др. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений (ВТЭО). Флебология. 2015;9(4-2):1-52.

6. Ross CB, Sterling KM, Carroll B, Rosovsky RP, Rivera-Lebron B, Merli G. The Pulmonary Embolism Response Team and Hospital Relationship. P. 1-30. DOI: 10.1007/978-3-030-70904-4_48-1. In: PERT Consortium Handbook of Pulmonary Embolism. Grodzin CJ, Merli GJ, Ross CB, Rosovsky R, editors - Cham: Springer International Publishing; - 2024. ISBN: 978-3-030-70904-4

7. Roncon L, Casazza F, Zuin M, Zonzin P, Galli M, Enea I. Percutaneous treatment of pulmonary embolism: diffusion and use of the technique in Italian interventional cardiology centers. Results of the PETER survey. Giornale Italiano di Cardiologia. 2016;17(4):268–72. DOI: 10.1714/2214.23900

8. Schultz J, Andersen A, Kabrhel C, Nielsen-Kudsk JE. Catheterbased therapies in acute pulmonary embolism. EuroIntervention. 2018;13(14):1721–7. DOI: 10.4244/EIJ-D-17-00437

9. Sista AK, Horowitz JM, Tapson VF, Rosenberg M, Elder MD, Schiro BJ et al. Indigo Aspiration System for Treatment of Pulmonary Embolism. JACC: Cardiovascular Interventions. 2021;14(3):319–29. DOI: 10.1016/j.jcin.2020.09.053

10. Garza JE, Shah P, Patel N, Wang D. Pulmonary Embolism With Syncope Treated With Inari FlowTriever®. Cureus. 2024;16(7):e64031. DOI: 10.7759/cureus.64031

11. Wang L, Yu C, Hu K, Guo Y, Li Y, Yu S et al. Research progress in interventional therapy for acute intermediate-high-risk and high-risk pulmonary embolism. Journal of Thoracic Disease. 2024;16(11):7958– 77. DOI: 10.21037/jtd-24-1049

12. Silver MJ, Gibson CM, Giri J, Khandhar S, Jaber W, Toma C et al. Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study. Circulation: Cardiovascular Interventions. 2023;16(10):e013406. DOI: 10.1161/CIRCINTERVENTIONS.123.013406

13. Gonsalves CF, Gibson CM, Stortecky S, Alvarez RA, Beam DM, Horowitz JM et al. Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study. American Heart Journal. 2023;266:128–37. DOI: 10.1016/j.ahj.2023.09.002

14. Pasha A, Ashraf M. Abstract 12155: Trends in the Clinical Outcomes and Resource Utilization of Catheter-Based Thrombolytic Therapy vs. Systemic Thrombolytic Therapy in Patients With Acute Pulmonary Embolism. Circulation. 2023;148(Suppl 1):12155. DOI: 10.1161/circ.148.suppl_1.12155

15. Monteleone P, Ahern R, Banerjee S, Desai KR, Kadian-Dodov D, Webber E et al. Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE). Journal of the Society for Cardiovascular Angiography & Interventions. 2024;3(1):101192. DOI: 10.1016/j.jscai.2023.101192

16. Zhang RS, Maqsood MH, Sharp ASP, Postelnicu R, Sethi SS, Greco A et al. Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism. JACC: Cardiovascular Interventions. 2023;16(21):2644–51. DOI: 10.1016/j.jcin.2023.07.042

17. Tefera L, Ziada KM, Cameron SJ. Pulmonary Embolism Unplugged: Catheter-Directed Therapies for Intermediate-Risk Pulmonary Embolism. JACC: Cardiovascular Interventions. 2023;16(21):2652–4. DOI: 10.1016/j.jcin.2023.08.029

18. Planer D, Yanko S, Matok I, Paltiel O, Zmiro R, Rotshild V et al. Cathe ter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis. Canadian Medical Association Journal. 2023;195(24):E833–43. DOI: 10.1503/cmaj.220960

19. Klok FA, Piazza G, Sharp ASP, Ní Ainle F, Jaff MR, Chauhan N et al. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study. American Heart Journal. 2022;251:43–53. DOI: 10.1016/j.ahj.2022.05.011

20. Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C et al. Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clinical and Applied Thrombosis/Hemostasis. 2019;25:1076029619853037. DOI: 10.1177/1076029619853037

21. Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): Creation of a Multidisciplinary Program to Improve Care of Patients With Massive and Submassive Pulmonary Embolism. Hospital Practice. 2014;42(1):31–7. DOI: 10.3810/hp.2014.02.1089

22. Hobohm L, Farmakis IT, Keller K, Scibior B, Mavromanoli AC, Sagoschen I et al. Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis. Clinical Research in Cardiology. 2023;112(10):1351–61. DOI: 10.1007/s00392-022-02077-0

23. DeVita MA, Bellomo R, Hillman K, Kellum J, Rotondi A, Teres D et al. Findings of the First Consensus Conference on Medical Emergency Teams. Critical Care Medicine. 2006;34(9):2463–78. DOI: 10.1097/01.CCM.0000235743.38172.6E

24. Meyer G, Vieillard-Baron A, Planquette B. Recent advances in the management of pulmonary embolism: focus on the critically ill patients. Annals of Intensive Care. 2016;6(1):19. DOI: 10.1186/s13613-016-0122-z

25. Rosenfield K, Rosovsky RP. Multidisciplinary Care for Pulmonary Embolism. 2017. Av. at: https://advances.massgeneral.org/cardiovascular/article.aspx?id=1007.

26. Mahar JH, Haddadin I, Sadana D, Gadre A, Evans N, Hornacek D et al. A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic. Journal of Thrombosis and Thrombolysis. 2018;46(2):186–92. DOI: 10.1007/s11239-018-1686-2

27. Chaudhury P, Gadre SK, Schneider E, Renapurkar RD, Gomes M, Haddadin I et al. Impact of Multidisciplinary Pulmonary Embolism Response Team Availability on Management and Outcomes. The American Journal of Cardiology. 2019;124(9):1465–9. DOI: 10.1016/j.amjcard.2019.07.043

28. Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. Journal of Thrombosis and Thrombolysis. 2019;47(1):31–40. DOI: 10.1007/s11239-018-1737-8

29. Kabrhel C, Jaff MR, Channick RN, Baker JN, Rosenfield K. A Multidisciplinary Pulmonary Embolism Response Team. Chest. 2013;144(5):1738–9. DOI: 10.1378/chest.13-1562

30. DeBerry J, Rali P, McDaniel M, Kabrhel C, Rosovsky R, Melamed R et al. Barriers and facilitators to interhospital transfer of acute pulmonary embolism: An inductive qualitative analysis. Frontiers in Medicine. 2023;10:1080342. DOI: 10.3389/fmed.2023.1080342

31. Lookstein RA, Bowers TR. Update on the PERCTM Initiative and the PERT Database: 1 Year Later. Endovascular Today Supplement. 2023;22(7):8–11. Av. at: https://assets.bmctoday.net/evtoday/pdfs/et0723_PERT_Supp_sec%202.pdf

32. Rosovsky R, Zhao K, Sista A, Rivera‐Lebron B, Kabrhel C. Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Research and Practice in Thrombosis and Haemostasis. 2019;3(3):315–30. DOI: 10.1002/rth2.12216

33. PERT Consortium. PE Centers of Excellence. Av. at: https://pertconsortium.org/centers-of-excellence/.

34. Васильева Е.Ю., Плавунов Н.Ф., Калинская А.И., Саввинова П.П., Сапина А.И., Введенский Г.А. и др. Организация ‘инфарктной сети’ в Москве и результаты ее работы за пятилетний период. Эндоваскулярная хирургия. 2018;5(2):288-94. DOI: 10.24183/2409-4080-2018-5-2-288-294

35. Шпектор А.В., Васильева Е.Ю. Острый инфаркт миокарда с подъемом сегмента ST: от ‘инфарктной сети’ к шок-центрам. Креативная кардиология. 2021;15(4):435-9. DOI: 10.24022/1997-3187-2021-15-4-435-439

36. Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC et al. Standardized Team-Based Care for Cardiogenic Shock. Journal of the American College of Cardiology. 2019;73(13):1659–69. DOI: 10.1016/j.jacc.2018.12.084

37. Alviar CL, Maqsood MH, Tehrani BN, Sinha S, Van Diepen S, Katz JN et al. Abstract 15975: Cardiogenic Shock Teams Are Associated With Lower Mortality, Bleeding and Vascular Complications: A Systematic Review and Meta-Analysis. Circulation. 2023;148(Suppl 1):15975. DOI: 10.1161/circ.148.suppl_1.15975

38. Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K et al. Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circulation: Heart Failure. 2024;17(11):e011709. DOI: 10.1161/CIRCHEARTFAILURE.124.011709

39. Elrod JK, Fortenberry JL. The hub-and-spoke organization design: an avenue for serving patients well. BMC Health Services Research. 2017;17(S1):457. DOI: 10.1186/s12913-017-2341-x

40. Calé R, Pereira H, Ferreira F, Loureiro MJ. Blueprint for developing an effective pulmonary embolism response network. Revista Portuguesa de Cardiologia. 2023;42(6):491–501. DOI: 10.1016/j.repc.2022.06.017